Dana BW - Search Results

1

Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.

Fisher RI, Dana BW, LeBlanc M, Kjeldsberg C, Forman JD, Unger JM, Balcerzak SP, Gaynor ER, Roy V, Miller T. Fisher RI, et al. Among authors: dana bw. J Clin Oncol. 2000 May;18(10):2010-6. doi: 10.1200/JCO.2000.18.10.2010. J Clin Oncol. 2000. PMID: 10811664 Clinical Trial.

2

Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study.

Weick JK, Dahlberg S, Fisher RI, Dana B, Miller TP, Balcerzak SP, Pierce HI. Weick JK, et al. J Clin Oncol. 1991 May;9(5):748-53. doi: 10.1200/JCO.1991.9.5.748. J Clin Oncol. 1991. PMID: 1707955 Clinical Trial.

3

m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial.

Dana BW, Dahlberg S, Miller TP, Hartsock RJ, Balcerzak S, Coltman CA, Carden JO, Hartley K, Fisher RI. Dana BW, et al. J Clin Oncol. 1990 Jul;8(7):1155-62. doi: 10.1200/JCO.1990.8.7.1155. J Clin Oncol. 1990. PMID: 1694233

4

Activity of esorubicin in recurrent malignant lymphoma: a Southwest Oncology Group study.

Miller TP, Dahlberg S, Salmon SE, Williamson SK, Belt RJ, Dana BW, Fisher RI. Miller TP, et al. Among authors: dana bw. J Clin Oncol. 1991 Jul;9(7):1204-9. doi: 10.1200/JCO.1991.9.7.1204. J Clin Oncol. 1991. PMID: 2045860 Clinical Trial.

5

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.

Dana BW, Dahlberg S, Nathwani BN, Chase E, Coltman C, Miller TP, Fisher RI. Dana BW, et al. J Clin Oncol. 1993 Apr;11(4):644-51. doi: 10.1200/JCO.1993.11.4.644. J Clin Oncol. 1993. PMID: 8478660 Clinical Trial.

6

Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

Fisher RI, Miller TP, Dana BW, Jones SE, Dahlberg S, Coltman CA Jr. Fisher RI, et al. Among authors: dana bw. Semin Hematol. 1987 Apr;24(2 Suppl 1):21-5. Semin Hematol. 1987. PMID: 2438778 Clinical Trial.

7

Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

Miller TP, Dana BW, Weick JK, Jones SE, Coltman CA, Dahlberg S, Fisher RI. Miller TP, et al. Among authors: dana bw. Semin Hematol. 1988 Apr;25(2 Suppl 2):17-22. Semin Hematol. 1988. PMID: 2456619

8

Mitoxantrone, cisplatin, and methyl-glyoxal bis-guanylhydrazone chemotherapy for refractory malignant lymphoma: a Southwest Oncology Group phase II trial.

Dana B, Dahlberg S, Schnitzer B, Kjeldsberg CR, Jones SE, Carden J, Mundis R, Tranum B. Dana B, et al. Invest New Drugs. 1989 Jul;7(2-3):247-50. doi: 10.1007/BF00170868. Invest New Drugs. 1989. PMID: 2793382 Free article.

9

Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.

Neuwelt EA, Goldman DL, Dahlborg SA, Crossen J, Ramsey F, Roman-Goldstein S, Braziel R, Dana B. Neuwelt EA, et al. J Clin Oncol. 1991 Sep;9(9):1580-90. doi: 10.1200/JCO.1991.9.9.1580. J Clin Oncol. 1991. PMID: 1875220

10

Evaluation of cis-platinum and DTIC combination chemotherapy in disseminated melanoma. A Southwest Oncology Group Study.

Fletcher WS, Green S, Fletcher JR, Dana B, Jewell W, Townsend RA. Fletcher WS, et al. Am J Clin Oncol. 1988 Oct;11(5):589-93. doi: 10.1097/00000421-198810000-00016. Am J Clin Oncol. 1988. PMID: 3177261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters